Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBCAR20A in r/r Non-Hodgkin Lymphoma or CLL/SLL
NCT04030195Phase 2Completed
- Sponsor
- Precision BioSciences, Inc.
- Start
- Mar 2020
- Primary completion
- Jun 2021
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of PBCAR20A in non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Precision BioSciences, Inc.. Started Mar 2020; status: completed.
02
Drugs
PBCAR20A
03
Conditions
non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT04030195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030195.